The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II study comparing bipolar androgen therapy vs. enzalutamide in asymptomatic men with castration resistant metastatic prostate cancer: The TRANSFORMER trial.
 
Benjamin A. Teply
Stock and Other Ownership Interests - BIND Therapeutics
Patents, Royalties, Other Intellectual Property - Massachusetts Institute of Technology
 
Emmanuel S. Antonarakis
Honoraria - Dendreon; Janssen Biotech; Medivation; Sanofi
Consulting or Advisory Role - Dendreon; Janssen Biotech; Medivation; Sanofi
Research Funding - Aragon Pharmaceuticals (Inst); Dendreon (Inst); Exelixis (Inst); Genentech (Inst); Janssen Biotech (Inst); Johnson & Johnson (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Dendreon; Medivation; Sanofi
 
Michael Anthony Carducci
Honoraria - Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Medivation
Research Funding - Amgen (Inst)
 
Channing Judith Paller
No Relationships to Disclose
 
Hao Wang
No Relationships to Disclose
 
Haiyi Cao
No Relationships to Disclose
 
Avery N. Spitz
No Relationships to Disclose
 
Jun Luo
Honoraria - Gilead Sciences
Consulting or Advisory Role - Astellas Pharma
Patents, Royalties, Other Intellectual Property - Tokai Pharmaceuticals
 
Mario A. Eisenberger
Honoraria - Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Ipsen
Research Funding - Genentech; Sanofi; Tokai Pharmaceuticals
Travel, Accommodations, Expenses - Astellas Pharma; Bayer
 
Samuel R. Denmeade
Patents, Royalties, Other Intellectual Property - GenSpera; Sophiris Bio